Siprashvili et al. found SNORD50A and SNORD50B were usually deleted in human cancer. Loss of SNORD50A and SNORD50B could increase the binding of K-RAS and hyper-activation of RAS-ERK1/ERK2 signalling to induce tumorigenesis [47]. The gene discussed is MAPK3; the disease is cancer.